Apex Biotechnology Corp. · TWSE:1733
Apex Biotechnology — Investor Conference 2022
14 slides from Apex Biotechnology's conference presentation, Jun 15, 2022
Slide 1: ApexBio Investor Conference June 2022
BYE 2h APEXBIO aiwan 2022 Jun APEXBIO
Slide 2: Company profile
Company profile Stock # TSEC 1733 Industry IVD Medical Device Head quarter: No. 7, Li-Hsin 5th Rd., Hsinchu Science Park, Hsinchu, Taiwan Operation Tao Yuan Factory: No. 180, Lane 70, Wuqing Rd., Dayuan Dist., Locations Taoyuan City 337, Taiwan Suzhou Corp.: Room 106, No.2, Kecheng Road, SIP, Suzhou
Slide 3: Milestone
Milestone 1997 ApexBio set-up 2007 Lactate launch 2017 Acquired Omnis Health LLC 1998 BGM FDA 510K approval 2008 Voice BGM launch Brazil ANVISA notified 1999 Uric Acid patent granted 2009 Taoyuan factory set-up 2018 ivCGM production set-up 2000 IPO listed to Taiwan OTC 2010 Tele-health tech build-up
Slide 4: Quality system
Quality system Region The Authority Regulatory compliance Taiwan TFDA GMP ISO 13485:2016 EU CE CE mark number:CE0197 EN ISO 15197:2015 510K’s USA FDA FDA on-site audit w/o 483 citations 2001/2006/2011/2016 China CFDA Medical Device Class II Japan PMDA Brazil ANVISA 2017 passed on-site audit
Slide 5: ESH policy
ESH policy In response to environmental protection and occupational safety and health policies, management procedures have been established year by year to consistently comply with the GRI guidelines in order to achieve the goal of sustainable of enterprises.
Slide 6: Product portfolio
Product portfolio Blood glucose monitoring systems Professional Monitoring systems Uric Acid Hemoglobin Lactate Ketone HbA1C Multi-functional systems Glucose + Glucose + Glucose + Glucose+Cholesterol Uric Acid Ketone Cholesterol + TG+Uric Acid
Slide 7: GLUCOSURE POC
GLUCOSURE POC Glucose/Ketone POC barcode scanner + wifi Ketone POC barcode scanner + wifi Hospital
Slide 8: Eclipse PLUS
Eclipse PLUS For Clinic and Hospital
Slide 9: Customized projects
Customized projects Product platform focus on electrochemistry/ strip photometry/immunology To derive new parameter tests and optimize our core platform. meter Sharing our advantage of regulation/quality control/ sales channels/clinical trails/manufacturing to alliance with partners and custom
Slide 10: Global sales distribution
Global sales distribution Territory 2020 2021 2022/1Q America 42% 43.5% 37% EU 46% 45% 55% Asia 11% 11% 8% Africa 1% 0.5% --
Slide 11: Finance Performance
Finance Performance 2020 2021 2022/1Q Revenue 2,005,337 2,132,656 521,954 Gross margin 452,224 571,512 132,305 Operation profit 103,328 204,949 39,740 Profit after tax 94,629 202,289 45,487 EPS 0.95 2.03 0.46 G/M ratio 22% 27% 25% Shipped Meter Qty (kit) 1,731K 1,677K 453K Shipped Strip Qty(pcs) 1,0
Slide 12: Product ratio
Product ratio 2021 2022/ 1Q BGM & A1C Electrode BGM & A1C Electrode Non-BGM Others Non-BGM Others 4% 3% 9% 18% 16% 14% 65% 71% Non-BGM Hemoglobin/Ketone/UricAcid/Lactate/Cholesterol/ Pesticide quick check etc
Slide 13: 8th Corporate Governance Evaluation (2021)
th the 8 Corporate Governance Evaluation (2021) Number of Points for Total number inapplicable Extra Credit Category weighting satisfied of indicators indicators Indicators: indicators Year 2020 2021 2020 2021 2020 2021 2020 2021 2020 2021 Protecting Shareholder Rights and Interests and Treating Sha
Slide 14: Thank you
Thank you APEXBIO